TP1701 |
RC-3095 TFA
|
1217463-61-0
|
98%
|
|
RC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.
|
TP2239L |
[D-Phe12]-Bombesin acetate
|
|
98%
|
|
[D-Phe12]-Bombesin acetate inhibits bombesin-stimulated secretion.
|
TP1916L1 |
[D-Phe12,Leu14]-Bombesin acetate
|
TP1916L1
|
98%
|
|
[D-Phe12,Leu14]-Bombesin acetate inhibits bombesin-stimulated secretion.
|
TP1281L1 |
Bombesin acetate(31362-50-2 free base)
|
1222319-87-0
|
98%
|
|
Bombesin acetate is a 14-amino acid peptide originally isolated from the skin of the European fire-bellied toad (Bombina bombina). It has two known homologs in m...
|
T10722 |
CD80-IN-3
|
486449-65-4
|
98%
|
|
CD80-IN-3 is a potent CD80 inhibitor and inhibits CD80/CD28 interaction (Kd: 125 nM; EC50: 630 nM).
|
T20604L |
Litorin acetate(55749-97-8 Free base)
|
|
98%
|
|
Litorin acetate, an amphibian bombesin peptide derivative, is an bombesin receptor agonist. It stimulates the contraction of smooth muscle, stimulates gastrin, g...
|
TP1913L1 |
BA 1 acetate(183241-31-8 free base)
|
TP1913L1
|
98%
|
|
BA 1 acetate is a potent bombesin receptor agonist (IC50 values are 0.26, 1.55 and 2.52 nM for BB1, BB2 and BB3 respectively). Enhances glucose transport in obes...
|
T4540 |
ML-18
|
1422269-30-4
|
98%
|
|
ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.
|
T3S1612 |
Kuwanon G
|
75629-19-5
|
98%
|
|
1. Kuwanon G as dual inhibitors of PTP1B and α-glucosidase enzymes, as well as insulin sensitizers, it may potentially be utilized as an effective treatment for ...
|
TN1849 |
Kuwanon H
|
76472-87-2
|
98%
|
|
Kuwanon H, and possibly kuwanon G also, are specific antagonists for the gastrin-releasing peptide (GRP) -preferring receptor and can be useful for studying the ...
|
T2126 |
MK-5046
|
1022152-70-0
|
98%
|
|
MK-5046 is a novel BRS-3 agonist, binding to BRS-3 with high affinity (mouse Ki = 1.6 nM, human Ki = 25 nM).
|